For example, niclosamide is currently FDA-approved as an anti-parasitic drug, yet treatment exhibited inhibition of IL-6-induced STAT3 activation resulting in suppression of adipocyte-induced EMT in breast cancer cells (176). This evidence concerns the gene STAT3 and breast carcinoma.